Non-Cytotoxic Nanomaterials Enhance Antimicrobial Activities of Cefmetazole against Multidrug-Resistant Neisseria gonorrhoeae

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Li, Lan Hui ^a,b   Yen, Muh Yong ^b,c   Ho, Chao Chi ^a   Wu, Ping ^a,c   Wang, Chien Chun ^b   Maurya, Pawan Kumar ^d   Chen, Pai Shan ^a   Chen, Wei ^e   Hsieh, Wan Yu ^a   Chen, Huei Wen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d AMITY UNIVERSITY   (India)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFMETAZOLE; MULTI WALLED NANOTUBE; NANOMATERIAL; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIUM ISOLATE; CASE REPORT; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ELECTRON MICROSCOPY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NEISSERIA GONORRHOEAE; NONHUMAN;

ANTI-INFECTIVE AGENTS; CEFMETAZOLE; CELL DEATH; CELL LINE; DRUG CARRIERS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; IONS; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; NANOSTRUCTURES; NEISSERIA GONORRHOEAE; PARTICLE SIZE; SILVER;

EID: 84877938957     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064794     Document Type: Article

References (45)

1. Wang CC, Celum CL, (1999) Global risk of sexually transmitted diseases. Med Clin North Am 83: 975-995.
2. Workowski KA, Berman SM, Douglas JJM, (2008) Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med 148(8): 606-613.
3. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines. MMWR 55(RR-11): 42-48.
4. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines. MMWR 59(RR-12): 49-55.
5. Ohnishi M, Saika T, Hoshina S, Iwasaku K, Nakayama SI, et al. (2011) Ceftriaxone-Resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis 17(1): 148-149.
6. Engel LS, (2009) Multidrug-Resistant Gram-Negative Bacteria: Trends, Risk Factors, and Treatments. Emerg Med 41(11): 18-27.
7. World Health Organization Department of Reproductive Health and Research. Emergence of multi-drug resistant Neisseria gonorrhoeae - Threat of global rise in untreatable sexually transmitted infections. 2011; WHO/RHR/11.14.
8. Blecher K, Nasir A, Friedman A, (2011) The growing role of nanotechnology in combating infectious disease. Virulence 2(5): 395-401.
9. Li Q, Mahendra S, Lyon DY, Brunet L, Liga MV, et al. (2008) Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications. Water Res 42(18): 4591-4602.
10. Kong H, Jang J, (2008) Synthesis and antimicrobial properties of novel silver/polyrhodanine nanofibers. Biomacromolecules 9(10): 2677-2681.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. CLSI, Wayne, PA, USA, 2009.
12. Yang CY, Meng CL, (1994) Regulation of PG Synthase by EGF and PDGF in Human Oral, Breast, Stomach, and Fibrosarcoma Cancer Cell Lines. J Dent Res 73: 1407-1415.
13. National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria-Sixth Edition; Approved Standard M11-A6, NCCLS, Wayne, PA, 2004.
14. Kim ES, Jeong SI, Kim JH, Park C, Kim SM, et al. (2009) Synergistic Effects of the Combination of 20-Hydroxyecdysone with Ampicillin and Gentamicin Against Methicillin-Resistant Staphylococcus aureus. J Microbiol Biotechnol 19(12): 1576-1581.
15. Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, Rodriguez-Padilla C, (2010) Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnology 8: 1.
16. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S, (2007) Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine 3: 168-171.
17. Sondi I, Salopek-Sondi B, (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275: 177-182.
18. Li WR, Xie XB, Shi QS, Duan SS, Ouyang YS, et al. (2010) Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol 85: 1115-1122.
19. Danilczuk M, Lund A, Sadlo J, (2006) Conduction electron spin resonance of small silver particles. Spectrochim Acta A Mol Biomol Spectrosc 63: 189-191.
20. dos Santos CA, Jozala AF, Pessoa A Jr, Seckler MM, (2012) Antimicrobial effectiveness of silver nanoparticles co-stabilized by the bioactive copolymer pluronic F68. J Nanobiotechnology 10: 43.
21. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, et al. (2007) Antimicrobial effects of silver nanoparticles. Nanomedicine 3: 95-101.
22. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, et al. (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52(4): 662-668.
23. Liu W, Wu Y, Wang C, Li HC, Wang T, et al. (2010) Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology 4(3): 319-330.
24. EI Badawy AM, Silva RG, Morris B, Scheckel KG, Suidan MT, et al. (2011) Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Technol 45(1): 283-287.
25. Powers CM, Badireddy AR, Ryde IT, Seidler FJ, Slotkin TA, (2011) Silver nanoparticles compromise neurodevelopment in PC12 cells: critical contributions of silver ion, particle size, coating, and composition. Environ Health Perspect 119(1): 37-44.
26. Pal S, Tak YK, Song JM, (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 27(6): 1712-1720.
27. Tian J, Wong KK, Ho CM, Lok CN, Yu WY, et al. (2007) Topical delivery of silver nanoparticles promotes wound healing. Chem Med Chem 2(1): 129-136.
28. Pratsinis A, Hervella P, Leroux JC, Pratsinis SE, Sotiriou GA (2013) Toxicity of Silver Nanoparticles in Macrophages. Small [Epub ahead of print].
29. Sotiriou G, Pratsinis A, (2010) Antibacterial Activity of Nanosilver Ions and Particles. Environ Sci Technol 44: 5649-5654.
30. Ruden S, Hilpert K, Berditsch M, Wadhwani P, Ulrich AS, (2009) Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial Peptides. Antimicrob Agents Chemother 53(8): 3538-3540.
31. Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, et al. (2008) The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 179: 130-139.
32. Park EJ, Yi J, Kim Y, Choi K, Park K, (2010) Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 24: 872-878.
33. Miura N, Shinohara Y, (2009) Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells. Biochem Biophys Res Commun 390: 733-737.
34. Vlachou E, Chipp E, Shale E, Wilson YT, Papini R, (2007) The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns 33(8): 979-985.
35. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, et al. (2006) Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 60(3): 648-652.
36. Hyun JS, Lee BS, Ryu HY, Christodoulides M, (2008) Effects of repeated silver nanoparticles exposure on the histological structure and mucins of nasal respiratory mucosa in rats. Toxicol Lett 179: 130-139.
37. Morones JR, Elechiguerra JL, Camacho A, Ramirez JT, (2005) The bactericidal effect of silver nanoparticles. Nanotechnology 16: 2346-2353.
38. Lara HH, Garza-Treviño EN, Ixtepan-Turrent L, Singh DK, (2011) Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J Nanobiotechnology 9: 30.
39. Chen M, Yang Z, Wu H, Pan X, Xie X, et al. (2011) Antimicrobial activity and the mechanism of silver nanoparticle thermosensitive gel. Int J Nanomedicine 6: 2873-2877.
40. Cortivo R, Vindigni V, Iacobellis L, Abatangelo G, Pinton P, et al. (2010) Nanoscale particle therapies for wounds and ulcers. Nanomedicine (Lond) 5: 641-656.
41. Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, et al. (2009) Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharm 6: 1388-1401.
42. Kurek A, Grudniak AM, Kraczkiewicz-Dowjat A, Wolska KI, (2011) New antibacterial therapeutics and strategies. Pol J Microbiol 60: 3-12.
43. Mohammed Fayaz A, Ao Z, Girilal M, Chen L, Xiao X, et al. (2012) Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection. Int J Nanomedicine 7: 5007-5018.
44. Abdel-Mohsen AM, Abdel-Rahman RM, Hrdina R, Imramovský A, Burgert L, et al. (2012) Antibacterial cotton fabrics treated with core-shell nanoparticles. Int J Biol Macromol 50: 1245-1253.
45. Makepeace BL, Watt PJ, Heckels JE, Christodoulides M, (2001) Interactions of Neisseria gonorrhoeae with mature human macrophage opacity proteins influence production of proinflammatory cytokines. Infect Immun 69: 1909-1913.